Congress trades
AptarGroup, Inc. (ATR)
Free on iOS and Android.
About AptarGroup, Inc.
from the company's filings and listing, as of Oct 22, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Gael Touya
- Employees
- 14,000
- Listed since
- Apr 23, 1993
- Market value
- $8.0B
- Price to earnings (12 mo)
- 22.4
- Net income per share, as reported (12 mo)
- $5.68
- Dividend yield
- 1.53%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $1.42 | $1.35 | $1.0B | $1.0B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $1.19 | $1.15 | $982.9M | $956.0M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 5, 2026 | $1.25 | $1.24 | $962.7M | $878.6M | EPS in lineRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $1.62 | $1.57 | $961.1M | $880.2M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 31, 2025 | $1.66 | $1.58 | $966.0M | $959.0M | EPS beat, GAAPRevenue in line |
| Q1 FY2025reported May 1, 2025 | $1.20 | $1.16 | $887.3M | $898.6M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Mar 27, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Stephan B. TandaPresident and Chief Executive Officer | $1.2M | $6.1M | $3.0M | $10.2M |
| Gael TouyaPresident, Aptar Pharma | $653K | $937K | $2.0M | $3.6M |
| Vanessa KanuExecutive Vice President and Chief Financial Officer | $720K | $2.0M | $869K | $3.6M |
| Hedi TliliPresident, Aptar Closures | $620K | $748K | $1.3M | $2.6M |
| Xiangwei GongExecutive Vice President, Strategic Group Development and President, Aptar Asia | $569K | $738K | $1.1M | $2.4M |
| Marc PrieurPresident, Aptar Beauty | $722K | $851K | $668K | $2.2M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $768.5M | 6,137,894 | +0.9% | 9.61% |
| State Farm Mutual Automobile Insurance Co | $594.0M | 4,744,564 | 0.0% | 7.43% |
| Vanguard Portfolio Management LLC | $455.6M | 3,638,724 | -3.4% | 5.70% |
| Morgan Stanley | $441.2M | 3,523,908 | +4.4% | 5.52% |
| Vanguard Capital Management LLC | $362.3M | 2,893,751 | +0.3% | 4.53% |
| State Street Corp | $358.5M | 2,863,390 | +2.8% | 4.47% |
| Victory Capital Management Inc | $319.8M | 2,554,561 | +5.6% | 4.00% |
| Geode Capital Management, LLC | $218.9M | 1,747,815 | +3.2% | 2.74% |
| Dimensional Fund Advisors LP | $218.0M | 1,741,294 | +15.7% | 2.73% |
| Neuberger Berman Group LLC | $193.9M | 1,548,824 | +31.9% | 2.43% |
| Fiduciary Management Inc | $178.3M | 1,423,771 | +13.7% | 2.23% |
| River Road Asset Management, LLC | $169.1M | 1,350,700 | +14.8% | 2.12% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ATR
16 disclosures of 16 on record · median 37d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | +7.7% since the tradeEstimated entry price $118.00, close on Wed Nov 19, 2025Current price $127.07, close on Mon Oct 26 | Nov 19, 2025 | Dec 9, 2025 | 20d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -7.3% since the tradeEstimated entry price $137.10, close on Thu Sep 11, 2025Current price $127.07, close on Mon Oct 26 | Sep 11, 2025 | Oct 10, 2025 | 29d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -4.3% since the tradeEstimated entry price $132.72, close on Mon Sep 22, 2025Current price $127.07, close on Mon Oct 26 | Sep 22, 2025 | Oct 10, 2025 | 18d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -9.6% since the tradeEstimated entry price $140.49, close on Thu Aug 7, 2025Current price $127.07, close on Mon Oct 26 | Aug 7, 2025 | Sep 11, 2025 | 35d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -9.6% since the saleEstimated exit price $140.64, close on Thu Aug 21, 2025Current price $127.07, close on Mon Oct 26 | Aug 21, 2025 | Sep 11, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | -17.4% since the tradeEstimated entry price $153.87, close on Tue Jun 24, 2025Current price $127.07, close on Mon Oct 26 | Jun 24, 2025 | Aug 13, 2025 | 50d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | n/a | Aug 26, 2024 | Sep 16, 2024 | 21d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | n/a | Nov 1, 2023 | Dec 9, 2023 | 38d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | n/a | Nov 1, 2023 | Dec 9, 2023 | 38d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | n/a | Aug 8, 2022 | Sep 19, 2022 | 42d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | n/a | Sep 11, 2019 | Oct 21, 2019 | 40d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | n/a | Sep 13, 2019 | Oct 21, 2019 | 38d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | n/a | Jul 12, 2019 | Aug 29, 2019 | 48d |
| Lizzie FletcherSpouse | Stock | Sale | $1,001 - $15,000 | n/a | Feb 26, 2019 | Apr 23, 2019 | 56d |
| Bradley Scott SchneiderSpouse | Stock | Sale | $250,001 - $500,000 | n/a | Mar 5, 2019 | Apr 6, 2019 | 32d |
| Bradley Scott SchneiderSpouse | Stock | Purchase | $250,001 - $500,000 | n/a | Feb 5, 2019 | Feb 17, 2019 | 12d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in ATR, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded ATR?
Michael T. McCaul, Lisa C. McClain, Susie Lee, Lizzie Fletcher and Bradley Scott Schneider disclosed ATR transactions in the filings shown here.
How quickly are ATR trades disclosed?
Congressional disclosures took a median of 37 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 28, 2026.